These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 29040829

  • 21. Inhibitory effect of Bowman-Birk protease inhibitor on autophagy in MDAMB231 breast cancer cell line.
    Kyani S, Akrami H, Mostafaei A, Akbari S, Salehi Z.
    J Cancer Res Ther; 2021; 17(2):504-509. PubMed ID: 34121699
    [Abstract] [Full Text] [Related]

  • 22. A four-nucleotide base-pair deletion in the coding region of the Bowman-Birk protease inhibitor gene prevents its accumulation in the seeds of Glycine microphylla PI440956.
    Krishnan HB, Kim WS.
    Planta; 2003 Jul; 217(3):523-7. PubMed ID: 12759752
    [Abstract] [Full Text] [Related]

  • 23. Immunoconjugates of soybean Bowman-Birk protease inhibitor as targeted antitumor polymeric agents.
    Gladysheva IP, Moroz NA, Karmakova TA, Nemtsova ER, Yakubovskaya RI, Larionova NI.
    J Drug Target; 2001 Jul; 9(5):303-16. PubMed ID: 11770701
    [Abstract] [Full Text] [Related]

  • 24. Acylation of Bowman-Birk soybean proteinase inhibitor by unsaturated fatty acid derivatives.
    Malykh EV, Tiourina OP, Larionova NI.
    Biochemistry (Mosc); 2001 Apr; 66(4):444-8. PubMed ID: 11403653
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of matrix metalloproteinase-1 activity by the soybean Bowman-Birk inhibitor.
    Losso JN, Munene CN, Bansode RR, Bawadi HA.
    Biotechnol Lett; 2004 Jun; 26(11):901-5. PubMed ID: 15269538
    [Abstract] [Full Text] [Related]

  • 26. Potential intracellular target proteins of the anticarcinogenic Bowman Birk protease inhibitor identified by affinity chromatography.
    Billings PC, St Clair W, Owen AJ, Kennedy AR.
    Cancer Res; 1988 Apr 01; 48(7):1798-802. PubMed ID: 3280120
    [Abstract] [Full Text] [Related]

  • 27. Effect of the Bowman-Birk inhibitor (a soy protein) on in vitro bladder neck/urethral and penile corporal smooth muscle activity.
    Malkowicz SB, Liu SP, Broderick GA, Wein AJ, Kennedy AR, Levin RM.
    Neurourol Urodyn; 2003 Apr 01; 22(1):54-7. PubMed ID: 12478602
    [Abstract] [Full Text] [Related]

  • 28. The Bowman-Birk inhibitor. Trypsin- and chymotrypsin-inhibitor from soybeans.
    Birk Y.
    Int J Pept Protein Res; 1985 Feb 01; 25(2):113-31. PubMed ID: 3886572
    [Abstract] [Full Text] [Related]

  • 29. Anti-carcinogenic soyabean Bowman-Birk inhibitors survive faecal fermentation in their active form and do not affect the microbiota composition in vitro.
    Marín-Manzano MC, Ruiz R, Jiménez E, Rubio LA, Clemente A.
    Br J Nutr; 2009 Apr 01; 101(7):967-71. PubMed ID: 19353764
    [Abstract] [Full Text] [Related]

  • 30. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase.
    Ware JH, Wan XS, Rubin H, Schechter NM, Kennedy AR.
    Arch Biochem Biophys; 1997 Aug 01; 344(1):133-8. PubMed ID: 9244390
    [Abstract] [Full Text] [Related]

  • 31. Bowman-Birk and Kunitz protease inhibitors among antinutrients and bioactives modified by germination and hydrolysis in Brazilian soybean cultivar BRS 133.
    Dia VP, Gomez T, Vernaza G, Berhow M, Chang YK, de Mejia EG.
    J Agric Food Chem; 2012 Aug 15; 60(32):7886-94. PubMed ID: 22800092
    [Abstract] [Full Text] [Related]

  • 32. Fabrication of a Soybean Bowman-Birk Inhibitor (BBI) Nanodelivery Carrier To Improve Bioavailability of Curcumin.
    Liu C, Cheng F, Yang X.
    J Agric Food Chem; 2017 Mar 22; 65(11):2426-2434. PubMed ID: 28249113
    [Abstract] [Full Text] [Related]

  • 33. The biochemical and functional food properties of the bowman-birk inhibitor.
    Losso JN.
    Crit Rev Food Sci Nutr; 2008 Jan 22; 48(1):94-118. PubMed ID: 18274967
    [Abstract] [Full Text] [Related]

  • 34. Suppression of 3-methylcholanthrene-induced cellular transformation by timed administration of the Bowman-Birk protease inhibitor.
    St Clair WH.
    Carcinogenesis; 1991 May 22; 12(5):935-7. PubMed ID: 2029760
    [Abstract] [Full Text] [Related]

  • 35. Gastric retention and stability of lipidized Bowman-Birk protease inhibitor in mice.
    Wang J, Shen WC.
    Int J Pharm; 2000 Aug 25; 204(1-2):111-6. PubMed ID: 11011993
    [Abstract] [Full Text] [Related]

  • 36. Effects of Disulfide Bond Reduction on the Conformation and Trypsin/Chymotrypsin Inhibitor Activity of Soybean Bowman-Birk Inhibitor.
    He H, Li X, Kong X, Zhang C, Hua Y, Chen Y.
    J Agric Food Chem; 2017 Mar 22; 65(11):2461-2467. PubMed ID: 28249116
    [Abstract] [Full Text] [Related]

  • 37. Binding of the soybean Bowman-Birk proteinase inhibitor and of its chymotrypsin and trypsin inhibiting fragments to bovine alpha-chymotrypsin and bovine beta-trypsin. A thermodynamic study.
    Ascenzi P, Amiconi G, Bolognesi M, Menegatti E, Guarneri M.
    J Mol Recognit; 1990 Mar 22; 3(5-6):192-6. PubMed ID: 2096886
    [Abstract] [Full Text] [Related]

  • 38. Interleukin-10 plays a crucial role in suppression of experimental autoimmune encephalomyelitis by Bowman-Birk inhibitor.
    Dai H, Ciric B, Zhang GX, Rostami A.
    J Neuroimmunol; 2012 Apr 22; 245(1-2):1-7. PubMed ID: 22365083
    [Abstract] [Full Text] [Related]

  • 39. Role of serine proteases in inflammation: Bowman-Birk protease inhibitor (BBI) as a potential therapy for autoimmune diseases.
    Safavi F, Rostami A.
    Exp Mol Pathol; 2012 Dec 22; 93(3):428-33. PubMed ID: 23022357
    [Abstract] [Full Text] [Related]

  • 40. Evidence that the Bowman-Birk inhibitor from Pisum sativum affects intestinal proteolytic activities in chickens.
    Moreau T, Recoules E, De Pauw M, Labas V, Réhault-Godbert S.
    Poult Sci; 2024 Jan 22; 103(1):103182. PubMed ID: 37931399
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.